Narrow search
Showing 1 - 6 of 6
Cover Image
The Impact of Recent Chemotherapy Innovation on the Longevity of Myeloma Patients: U.S. and International Evidence
Lichtenberg, Frank; Hostenkamp, Gisela - 2013
There were no innovations in chemotherapy for myeloma patients during the period 1977-1997, but there have been several important innovations since 1997. We investigate the impact of recent chemotherapy innovation on the longevity of myeloma patients using both time-series U.S. data and...
Persistent link: https://www.econbiz.de/10010328754
Cover Image
Listen to your doctor, or else! : medication under-use and overuse and long-term health outcomes of Danish diabetes patients
Hostenkamp, Gisela; Lichtenberg, Frank R. - 2015
Persistent link: https://www.econbiz.de/10011428372
Cover Image
The impact of recent chemotherapy innovation on the longevity of Myeloma patients : U.S. and international evidence
Lichtenberg, Frank R.; Hostenkamp, Gisela - 2013
There were no innovations in chemotherapy for myeloma patients during the period 1977-1997, but there have been several important innovations since 1997. We investigate the impact of recent chemotherapy innovation on the longevity of myeloma patients using both time-series U.S. data and...
Persistent link: https://www.econbiz.de/10010223067
Cover Image
How much is enough? : Efficiency and medicare spending in the last six months of life
Skinner, Jonathan; Wennberg, John E. - In: The changing hospital industry : comparing …, (pp. 169-193). 2000
Persistent link: https://www.econbiz.de/10001515700
Cover Image
Market forces, diversification of activity, and the mission of not-for-profit hospitals
Frank, Richard G.; Salkever, David S. - In: The changing hospital industry : comparing …, (pp. 195-215). 2000
Persistent link: https://www.econbiz.de/10001515716
Cover Image
The Impact of Recent Chemotherapy Innovation on the Longevity of Myeloma Patients: U.S. and International Evidence
Lichtenberg, Frank; Hostenkamp, Gisela - CESifo - 2013
There were no innovations in chemotherapy for myeloma patients during the period 1977-1997, but there have been several important innovations since 1997. We investigate the impact of recent chemotherapy innovation on the longevity of myeloma patients using both time-series U.S. data and...
Persistent link: https://www.econbiz.de/10010723537